Literature DB >> 27578472

Asthma control in patients treated with inhaled corticosteroids and long-acting beta agonists: A population-based analysis in Germany.

Anke Kondla1, Thomas Glaab1, Riccardo Pedersini2, Marek Lommatzsch3.   

Abstract

BACKGROUND: The prevalence and the characteristics of poor asthma control among adults treated with combinations of inhaled corticosteroids (ICS) and long-acting beta-agonists (LABA) are not completely understood.
METHODS: Data from adult patients in Germany with self-reported asthma treated with an ICS-LABA combination in the National Health and Wellness Survey (NHWS) were analysed. Patients with well-controlled and not well-controlled asthma according to the Asthma Control Test (ACT) score were compared, with respect to socio-demographic characteristics, attitudes, adherence and outcomes.
RESULTS: Among the German patients with self-reported asthma (5.2% of the respondents), 16.2% (382 patients) were treated with an ICS-LABA combination and did not report concomitant chronic obstructive pulmonary disease, chronic bronchitis or emphysema. In this subgroup, 55.8% had not well-controlled asthma (ACT < 20). ICS-LABA treated patients with not well-controlled asthma were more likely to report emergency visits (16.4% vs. 8.9%), missed more time from work (absenteeism: 12.9% vs. 4.3%), were more impaired while at work (presenteeism: 29.0% vs. 14.9%) and were more likely to be women (69.0% vs. 57.4%), compared with well-controlled patients. There were no significant differences in age, body mass index, smoking, income, education or self-reported adherence between the two groups, but different attitudes regarding the patient-physician relationship.
CONCLUSIONS: A substantial proportion of patients treated with ICS and LABA had not well-controlled asthma. These patients did not differ from well-controlled patients in terms of education or self-reported adherence, but in terms of their attitudes regarding the patient-physician relationship.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Asthma control; Germany; Inhaled corticosteroids (ICS); Long-acting beta-agonitsts (LABA); Quality of life

Mesh:

Substances:

Year:  2016        PMID: 27578472     DOI: 10.1016/j.rmed.2016.07.012

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  2 in total

1.  The impact of poor asthma control among asthma patients treated with inhaled corticosteroids plus long-acting β2-agonists in the United Kingdom: a cross-sectional analysis.

Authors:  Ian D Pavord; Nicola Mathieson; Anna Scowcroft; Riccardo Pedersini; Gina Isherwood; David Price
Journal:  NPJ Prim Care Respir Med       Date:  2017-03-09       Impact factor: 2.871

2.  Asthma control is associated with economic outcomes, work productivity and health-related quality of life in patients with asthma.

Authors:  Lulu K Lee; Karthik Ramakrishnan; Guilherme Safioti; Rinat Ariely; Michael Schatz
Journal:  BMJ Open Respir Res       Date:  2020-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.